全文获取类型
收费全文 | 4804篇 |
免费 | 409篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 12篇 |
儿科学 | 156篇 |
妇产科学 | 173篇 |
基础医学 | 735篇 |
口腔科学 | 54篇 |
临床医学 | 578篇 |
内科学 | 843篇 |
皮肤病学 | 111篇 |
神经病学 | 442篇 |
特种医学 | 99篇 |
外科学 | 311篇 |
综合类 | 58篇 |
一般理论 | 6篇 |
预防医学 | 637篇 |
眼科学 | 69篇 |
药学 | 527篇 |
中国医学 | 2篇 |
肿瘤学 | 406篇 |
出版年
2023年 | 39篇 |
2022年 | 62篇 |
2021年 | 101篇 |
2020年 | 75篇 |
2019年 | 129篇 |
2018年 | 124篇 |
2017年 | 96篇 |
2016年 | 146篇 |
2015年 | 120篇 |
2014年 | 205篇 |
2013年 | 266篇 |
2012年 | 384篇 |
2011年 | 353篇 |
2010年 | 187篇 |
2009年 | 187篇 |
2008年 | 288篇 |
2007年 | 353篇 |
2006年 | 305篇 |
2005年 | 311篇 |
2004年 | 288篇 |
2003年 | 228篇 |
2002年 | 275篇 |
2001年 | 45篇 |
2000年 | 35篇 |
1999年 | 45篇 |
1998年 | 59篇 |
1997年 | 42篇 |
1996年 | 45篇 |
1995年 | 33篇 |
1994年 | 35篇 |
1993年 | 33篇 |
1992年 | 14篇 |
1991年 | 25篇 |
1990年 | 12篇 |
1989年 | 18篇 |
1988年 | 14篇 |
1987年 | 19篇 |
1986年 | 11篇 |
1985年 | 15篇 |
1984年 | 10篇 |
1983年 | 11篇 |
1982年 | 20篇 |
1981年 | 15篇 |
1980年 | 15篇 |
1978年 | 9篇 |
1977年 | 9篇 |
1974年 | 11篇 |
1973年 | 10篇 |
1971年 | 8篇 |
1968年 | 9篇 |
排序方式: 共有5219条查询结果,搜索用时 15 毫秒
51.
52.
Hormone-refractory breast cancer remains sensitive to the antitumor activity of heat shock protein 90 inhibitors. 总被引:8,自引:0,他引:8
Jason Beliakoff Rochelle Bagatell Gillian Paine-Murrieta Charles W Taylor Anne E Lykkesfeldt Luke Whitesell 《Clinical cancer research》2003,9(13):4961-4971
PURPOSE: The antiestrogen tamoxifen (Tam) has been used as therapy against estrogen receptor (ER)-positive breast cancer for decades. Most tumors respond initially, but resistance frequently develops. The ER exists in a multiprotein complex containing the molecular chaperone heat shock protein (Hsp) 90, which is known to regulate the stability and activity of this receptor. Therefore, we investigated a ligand-independent approach to hormonal therapy that depletes cellular levels of the receptor by inhibiting the function of Hsp90. EXPERIMENTAL DESIGN: The activity of the Hsp90 inhibitor geldanamycin (GA) and its clinically relevant derivative, 17-allylamino-17-demethoxygeldanamycin (17AAG), was examined at the molecular and cellular levels using Tam-resistant MCF-7 breast cancer cells both in vitro and in tumor xenografts. RESULTS: The ER was depleted by GA in several Tam-resistant cell lines, as were other Hsp90 client proteins such as Akt and Raf-1. Unexpectedly, Tam inhibited ER depletion by GA but had no effect on destabilization of Akt or Raf-1. When SCID mice supplemented with Tam were treated with 17AAG, their tumors also showed no decrease in ER levels as measured by immunofluorescent staining and laser scanning cytometry. In these same tumors, however, decreased Akt and Raf-1 levels were observed. Drug administration also led to inhibition of tumor xenograft growth. The mechanism by which Tam inhibits GA-mediated ER depletion is unclear, but immunoprecipitation experiments showed that Tam does not inhibit the ability of GA to alter the ER-chaperone complex. CONCLUSIONS: Based on its ability to deplete the ER as well as other critical signaling molecules in Tam-resistant breast cancer, 17AAG may provide a useful alternative treatment for patients with recurrent, hormone-refractory breast cancer that should be explored further in Phase II trials. In this context, combined treatment with 17AAG and Tam should be avoided because Tam may inhibit the ability of 17AAG to deplete the ER, potentially reducing its anticancer activity. 相似文献
53.
Margaret R.E. McCredie Gillian S. Dite Graham G. Giles John L. Hopper 《Cancer causes & control : CCC》1998,9(2):189-198
Objectives: A case-control-family study of breast cancer in women under the age of 40 was carried out in Melbourne and Sydney, Australia, from 1992 to 1995 to determine the risk factors for these women. Subjects included 467 incident cases identified by state cancer registries and 408 population-based controls. Methods: All participants completed a structured risk-factor questionnaire and family pedigree during an in-person interview. Where possible, cancers in first- and second-degree relatives were verified. Results: Multiple logistic regression analysis showed that the strongest risk factor for breast cancer was a family history of the disease - having at least one affected first-degree relative trebled the risk (relative risk [RR] = 3.3, 95 percent confidence interval [CI] = 1.9-5.8). Risk increased with height by three percent (standard error [SE] of one percent) per cm, and after adjusting for height, there was evidence for a decreased risk in women weighing 73 kg or more. There was an increased risk of breast cancer after the first full-term birth (RR = 1.8, CI = 1.0-3.5) but this risk fell by 30 percent (SE = 11 percent) with each subsequent livebirth. Conclusions: The effects of other reproductive factors and oral contraceptive use, although not nominally significant, were in accord with published findings from similar studies in young women. This study of Australian women has indicated that some risk factors for breast cancer in women under age 40 differ from those reported for older women either in direction (e.g., weight) or relative importance (e.g., family history). 相似文献
54.
Rosie Ashbolt Jenny Barralet Robert Bell Dennis Bittisnich Andrew Black Barry Combs Christine Carson Scott Crerar Craig Dalton Joy Gregory Michelle Harlock Gillian Hall Geoff Hogg Martyn Kirk Karin Lalor Tony Merritt Sally Munnoch Jennie Musto Lillian Mwanri Leonie Neville Chris Oxenford Rhonda Owen Jane Raupach Cameron Sault Russell Stafford Barbara Telfer Hassan Vally Kefle Yohannes 《Communicable diseases intelligence》2005,29(1):85-88
55.
56.
Judi Cunningham Gillian Harris Panos Vostanis Femi Oyebode Jackie Blissett 《Early child development and care》2004,174(7):639-650
This study describes the pattern of emotional and behavioural difficulties of children whose mothers have mental illness, and explores the relationship between children's behavioural and emotional difficulties and maternal perceptions of attachment. Thirteen mothers previously admitted to psychiatric hospital for mental illness completed a measure of their own symptoms (Brief Symptom Inventory), their children's emotional and behavioural problems (Strengths and Difficulties Questionnaire (SDQ)), and attachment security (Parent/Child Reunion Inventory) (n = 21). Mean scores for child SDQ profiles were found to be within the 'normal' range, although (on some indices) mothers reported more 'case' scores for their children, than would be expected from standardized norms. It was found that there were significant positive correlations between 'insecurity' scores and all problem scales of the SDQ. Best predictors from the Parent/Child Reunion Inventory factors for each SDQ scale are reported and discussed. 相似文献
57.
58.
Kenneth W Yip Joseph D Mocanu P Y Billie Au Gillian T Sleep Dolly Huang Pierre Busson Wen-Chen Yeh Ralph Gilbert Brian O'Sullivan Patrick Gullane Carlo Bastianutto Fei-Fei Liu 《Clinical cancer research》2005,11(22):8131-8144
PURPOSE: A wide variety of tumors depend on the dysregulation of Bcl-2 family proteins for survival. The resulting apoptotic block can often provide a mechanism for resistance to anticancer treatments, such as chemotherapy and radiation. This current study evaluates the efficacy of combining systemically delivered Bcl-2 phosphorothioate antisense (Bcl-2 ASO) and radiation for nasopharyngeal cancer therapy. RESULTS: Antisense uptake was unaffected by 0, 3, or 6 Gy radiation. Radiation decreased the fraction of viable C666-1 cells to 60%, with a further decrease to 40% in combination with Bcl-2 ASO. Despite a modest in vitro effect, Bcl-2 ASO alone caused the regression of established xenograft tumors in mice, extending survival by 15 days in a C666-1 and by 6 days in a C15 model. The survival times for mice treated with both Bcl-2 ASO and radiation increased by 52 days in C666-1 and by 20 days in C15 tumors. This combination resulted in a more-than-additive effect in C666-1 tumors. Less impressive gains observed in C15 tumors might be attributable to higher expression of antiapoptotic Bcl-2 family proteins and limited drug distribution in the tumor. Retreatment of C666-1 tumors with the Bcl-2 ASO-radiation combination, however, was effective, resulting in mice surviving for >80 days relative to untreated controls. CONCLUSIONS: Our results show that the Bcl-2 ASO and radiation combination is a highly potent therapy for nasopharyngeal cancer. Further examination of combination therapy with radiation and other Bcl-2 family-targeted anticancer agents in both preclinical and clinical settings is definitely warranted. 相似文献
59.
Emily Banks Gillian Reeves Valerie Beral Diana Bull Barbara Crossley Moya Simmonds Elizabeth Hilton Stephen Bailey Nigel Barrett Peter Briers Ruth English Alan Jackson Elizabeth Kutt Janet Lavelle Linda Rockall Matthew G Wallis Mary Wilson Julietta Patnick 《British medical journal》2004,328(7451):1291-1292
60.
Gillian Ray-Barruel Denise F. Polit Jenny Murfield Claire M. Rickard 《Journal of the Association for Vascular Access》2013,18(4):217-218
The American Society for Microbiology recommends a standard of 3% or less for blood culture contamination rates. The purpose of this study was to evaluate blood culture bundles on the blood culture contamination rates when blood culture was obtained through a central venous access device (CVAD). The study utilizes a non-experimental pre/post audit intervention design. The pre audit rates were compared to post audit rates of contamination after introduction of blood culture bundle. Mean results 相似文献